Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia or Schizoaffective”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Post-approval studies (Phase 4)Looking for participantsNCT06740890
What this trial is testing

Exercise and Olanzapine-samidorphan

Who this might be right for
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder I or II+1 more
New York State Psychiatric Institute 30
Post-approval studies (Phase 4)Study completedNCT00634348
What this trial is testing

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 256
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Not applicableStudy completedNCT01729650
What this trial is testing

Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)

Who this might be right for
Schizophrenic DisordersSchizoaffective DisordersBipolar Disorders
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 332
Post-approval studies (Phase 4)Study completedNCT00061802
What this trial is testing

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 225
Large-scale testing (Phase 3)Study completedNCT00236353
What this trial is testing

Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 86
Not applicableUnknownNCT02665611
What this trial is testing

Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Assuta Hospital Systems 300
Early research (Phase 1)Study completedNCT00796185
What this trial is testing

As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 62
Large-scale testing (Phase 3)Study completedNCT00297947
What this trial is testing

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 60
Post-approval studies (Phase 4)UnknownNCT06093451
What this trial is testing

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Who this might be right for
Schizophrenia AgitationSchizo Affective DisorderBipolar Disorder+1 more
Temple University 32
Early research (Phase 1)Study completedNCT02411526
What this trial is testing

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Zogenix, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01267188
What this trial is testing

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia

Who this might be right for
Tardive Dyskinesia
Neurocrine Biosciences 10
Large-scale testing (Phase 3)Ended earlyNCT00660595
What this trial is testing

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

Who this might be right for
Schizophrenic Disorders
AstraZeneca 29
Early research (Phase 1)Study completedNCT01074632
What this trial is testing

Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl

Who this might be right for
Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Sumitomo Pharma America, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT01450514
What this trial is testing

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

Who this might be right for
Chronic SchizophreniaSchizoaffective Disorder
PharmaNeuroBoost N.V. 7
Early research (Phase 1)Study completedNCT01082289
What this trial is testing

Digoxin Drug-Drug Interaction With Lurasidone HCl

Who this might be right for
Schizophrenia
Sumitomo Pharma America, Inc. 24
Early research (Phase 1)Study completedNCT06627413
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia or Schizoaffective
Intra-Cellular Therapies, Inc. 52
Not applicableUnknownNCT03974620
What this trial is testing

Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
Pakistan Institute of Living and Learning 120
Large-scale testing (Phase 3)Study completedNCT00347425
What this trial is testing

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Who this might be right for
Schizophrenia and Schizoaffective Disorder
Solvay Pharmaceuticals 286
Post-approval studies (Phase 4)UnknownNCT01016145
What this trial is testing

Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm

Who this might be right for
Schizophrenia or Schizoaffective Disorder
University of Sao Paulo 126
Next Page